Vertex Pharmaceuticals Inc (VRTX) Financials
Key financial figures for Vertex Pharmaceuticals Inc (Q1 2026).
- Revenue
- $3.0B
- Net Income
- $1.0B
- EPS
- $4.06
- Total Assets
- $26.5B
- Operating Cash Flow
- $1.4B
Full income statement, balance sheet, and cash flow for Vertex Pharmaceuticals Inc on SentiSense.